92597 Insurance Policy Changes

CPT 92597, in plain terms, covers The clinician assesses the patient and fits or trials a voice prosthesis that supplements oral speech, often after laryngectomy. This covers the evaluation, not ongoing therapy. CPT 92597 is referenced in 3 tracked payer policy changes from Excellus BlueCross BlueShield and Aetna. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for CPT 92597 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.

Official descriptor: CPT 92597 on AAPC

Excellus BlueCross BlueShield · Effective Aug 20, 2026Medium impact
Augmentative and Alternative Communication Systems (e.g., Speech-generating Devices) 1.01.03
Effective August 20, 2026, augmentative and alternative communication devices, including speech generating devices, are considered medically appropriate when all criteria are met. The criteria include a formal evaluation by a speech-language pathologist that documents the communication impairment, a technological assessment, functional goals, a training plan, and a request for a minimum one-month trial with documented effectiveness. Documentation from an appropriate health professional must show the patient has the cognitive and physical abilities to use the device, the device must be expected to benefit the patient's speech disability, and the device must not have been selected primarily for the convenience of the patient, family, or providers. Replacement of properly functioning devices is considered not medically necessary. The 2025 annual review updated the DME repair and replacement statements, and the 2026 annual review left the policy intent unchanged.
Aetna · Identified Oct 1, 2026Medium impact
Voice Therapy (CPB 0646, reviewed 2026-09-09)
Aetna considers voice therapy medically necessary to restore the ability to produce speech sounds from the larynx for essential voice tremor, surgery or traumatic injury to the vocal cords, treatment for laryngeal (glottic) carcinoma, muscle tension dysphonia, paradoxical vocal cord motion, post-laryngectomy esophageal speech production, spastic dysphonia, symptomatic benign vocal fold lesions, and vocal cord paralysis. Aetna considers voice therapy not medically necessary for improving voice quality, for occupational or recreational purposes, for self-limited conditions such as acute laryngitis, or as maintenance treatment where symptoms are not improving. Pre-operative voice therapy for benign vocal fold lesions and voice therapy for vocal fold motion impairment following chemotherapy are considered experimental, investigational, or unproven, and voice therapy to feminize or masculinize the voice for transgender individuals is considered not medically necessary and cosmetic.
Aetna · Identified Aug 14, 2026Medium impact
Voice Therapy (CPB 0646, reviewed 2025-12-08)
Aetna considers voice therapy medically necessary to restore the ability to produce speech sounds from the larynx for essential voice tremor, surgery or traumatic injury to the vocal cords, treatment for laryngeal (glottic) carcinoma, muscle tension dysphonia, paradoxical vocal cord motion, post-laryngectomy esophageal speech production, spastic dysphonia, symptomatic benign vocal fold lesions, and vocal cord paralysis. Voice therapy is not medically necessary to improve voice quality, for occupational or recreational purposes, or for self-limited conditions such as acute laryngitis, and maintenance treatment where symptoms are not improving is not medically necessary. Pre-operative voice therapy for improving outcomes of surgery for benign vocal fold lesions, and voice therapy for vocal fold motion impairment following chemotherapy, are considered experimental, investigational, or unproven.

Watch 92597

Get one email when a payer policy names 92597, a payer adds or drops it from a prior auth list, or Medicare changes its NCCI pairs, unit limit, payment or coverage articles.

No account needed. We send a confirmation link first, and every email has a one-click stop link.

REFERENCE DATA

Payers with rules3

Payers requiring prior auth3

BCBS Illinois · Effective October 1, 2026
Prior authorization required in some cases
Blue Cross Community Health Plans (Illinois Medicaid) Prior Authorization Code List
CalViva Health · Effective December 31, 2025
Prior authorization required
CalViva Health CMS-0057-F prior authorization requirements
Community Health Plan of Imperial Valley · Effective December 31, 2025
Prior authorization required
Community Health Plan of Imperial Valley CMS-0057-F prior authorization requirements

FREQUENTLY ASKED QUESTIONS

Does BCBS Illinois require prior authorization for 92597?

BCBS Illinois lists 92597 on Blue Cross Community Health Plans (Illinois Medicaid) Prior Authorization Code List for medicaid managed plans, with conditions (list dated October 1, 2026). Verify with the payer before scheduling.

Does CalViva Health require prior authorization for 92597?

CalViva Health lists 92597 on CalViva Health CMS-0057-F prior authorization requirements for medicaid managed plans (list dated December 31, 2025). Verify with the payer before scheduling.

Does Community Health Plan of Imperial Valley require prior authorization for 92597?

Community Health Plan of Imperial Valley lists 92597 on Community Health Plan of Imperial Valley CMS-0057-F prior authorization requirements for medicaid managed plans (list dated December 31, 2025). Verify with the payer before scheduling.

What insurance policy changes affect CPT 92597?

There are 3 tracked policy changes affecting CPT 92597, including updates from Excellus BlueCross BlueShield, Aetna. Each change may modify coverage criteria, reimbursement rates, or prior-authorization requirements.

Which payers have updated policy for CPT 92597?

Payers that have issued tracked updates for CPT 92597 include: Excellus BlueCross BlueShield, Aetna.

How do I get notified when CPT 92597 policy changes?

Create a free account at PolicyChanges.app and save a search filtered to CPT 92597. You will get an email when new policy changes reference this code: daily or weekly, your choice, on every plan.

Why do payers change policies for CPT 92597?

Payers revise policies for individual billing codes to align with updated clinical guidelines, CMS rule changes, fraud and abuse prevention measures, or network cost-management goals. Changes can affect medical necessity criteria, place-of-service restrictions, bundling rules, or whether a code requires prior authorization.

See every payer rule for 92597

Prior authorization lists, coverage criteria, NCCI edits and Medicare coverage articles for 92597 in one place.

See every payer rule

All billing codes J3590 C9399 J3490 99215 99213 99202

Get alerts for changes like this

Save a search and get email alerts when a new policy change matches your filters: daily or weekly, your choice, on every plan.

Create a free alert How Policy Monitoring works

Augmentative and Alternative Communication Systems (e.g., Speech-generating Devices) 1.01.03

Voice Therapy (CPB 0646, reviewed 2026-09-09)

Voice Therapy (CPB 0646, reviewed 2025-12-08)

Prior authorization required in some cases

Prior authorization required